German biotechnology firm BioNTech, based by Turkish-German immigrants and famed for its mRNA technology-based COVID-19 vaccine, has introduced that it initiated an early-stage scientific trials
German biotechnology firm BioNTech, based by Turkish-German immigrants and famed for its mRNA technology-based COVID-19 vaccine, has introduced that it initiated an early-stage scientific trials